Leuprolide Completed Phase N/A Trials for Breast Cancer

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02134977Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: QOL Survey in Premenopausal Breast Cancer Patients
NCT02154139Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)